Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning

Miguel C. Fernandez, Frank G Walter, James C. Kloster, Sean M. O'Brien, Lesley A. Brady, Al Villarin, Stephen J. Ruffenach, Eric H. Prosnitz, Julia V. Salmon

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A 31-y-old epileptic man developed coma and shock after suicidally ingesting large amounts of valproic acid and gabapentin. His peak valproic acid level was 1306.9 μg/mL (therapeutic range = 30-100 μg/mL). His peak gabapentin level was 60.0 μg/mL (therapeutic range = 2.0-8.0 μg/mL). His hypotension was refractory to crystalloid and pressor infusions, but resolved during concurrent hemoperfusion and hemodialysis to enhance elimination of valproic acid. Concurrent hemoperfusion and hemodialysis, in series, produced a maximum valproic acid plasma clearance of 55.4 mL/min versus a maximum reported intrinsic valproic acid plasma clearance of 10.6 mL/min. Concurrent hemoperfusion and hemodialysis, in series, should be considered in hemodynamically unstable patients with valproic acid poisoning whose clinical condition is worsening in spite of aggressive supportive care.

Original languageEnglish (US)
Pages (from-to)438-443
Number of pages6
JournalVeterinary and Human Toxicology
Volume38
Issue number6
StatePublished - Dec 1996

Fingerprint

valproic acid
Hemoperfusion
hemodialysis
Valproic Acid
Poisoning
Renal Dialysis
poisoning
Therapeutics
Plasmas
coma
therapeutics
hypotension
Coma
Refractory materials
Hypotension
gabapentin
Shock

ASJC Scopus subject areas

  • veterinary(all)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Fernandez, M. C., Walter, F. G., Kloster, J. C., O'Brien, S. M., Brady, L. A., Villarin, A., ... Salmon, J. V. (1996). Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning. Veterinary and Human Toxicology, 38(6), 438-443.

Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning. / Fernandez, Miguel C.; Walter, Frank G; Kloster, James C.; O'Brien, Sean M.; Brady, Lesley A.; Villarin, Al; Ruffenach, Stephen J.; Prosnitz, Eric H.; Salmon, Julia V.

In: Veterinary and Human Toxicology, Vol. 38, No. 6, 12.1996, p. 438-443.

Research output: Contribution to journalArticle

Fernandez, MC, Walter, FG, Kloster, JC, O'Brien, SM, Brady, LA, Villarin, A, Ruffenach, SJ, Prosnitz, EH & Salmon, JV 1996, 'Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning', Veterinary and Human Toxicology, vol. 38, no. 6, pp. 438-443.
Fernandez MC, Walter FG, Kloster JC, O'Brien SM, Brady LA, Villarin A et al. Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning. Veterinary and Human Toxicology. 1996 Dec;38(6):438-443.
Fernandez, Miguel C. ; Walter, Frank G ; Kloster, James C. ; O'Brien, Sean M. ; Brady, Lesley A. ; Villarin, Al ; Ruffenach, Stephen J. ; Prosnitz, Eric H. ; Salmon, Julia V. / Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning. In: Veterinary and Human Toxicology. 1996 ; Vol. 38, No. 6. pp. 438-443.
@article{2a3a23bca5914416bbcf91894adf2072,
title = "Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning",
abstract = "A 31-y-old epileptic man developed coma and shock after suicidally ingesting large amounts of valproic acid and gabapentin. His peak valproic acid level was 1306.9 μg/mL (therapeutic range = 30-100 μg/mL). His peak gabapentin level was 60.0 μg/mL (therapeutic range = 2.0-8.0 μg/mL). His hypotension was refractory to crystalloid and pressor infusions, but resolved during concurrent hemoperfusion and hemodialysis to enhance elimination of valproic acid. Concurrent hemoperfusion and hemodialysis, in series, produced a maximum valproic acid plasma clearance of 55.4 mL/min versus a maximum reported intrinsic valproic acid plasma clearance of 10.6 mL/min. Concurrent hemoperfusion and hemodialysis, in series, should be considered in hemodynamically unstable patients with valproic acid poisoning whose clinical condition is worsening in spite of aggressive supportive care.",
author = "Fernandez, {Miguel C.} and Walter, {Frank G} and Kloster, {James C.} and O'Brien, {Sean M.} and Brady, {Lesley A.} and Al Villarin and Ruffenach, {Stephen J.} and Prosnitz, {Eric H.} and Salmon, {Julia V.}",
year = "1996",
month = "12",
language = "English (US)",
volume = "38",
pages = "438--443",
journal = "Veterinary and Human Toxicology",
issn = "0145-6296",
publisher = "Comparative Toxicology Laboratories",
number = "6",

}

TY - JOUR

T1 - Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning

AU - Fernandez, Miguel C.

AU - Walter, Frank G

AU - Kloster, James C.

AU - O'Brien, Sean M.

AU - Brady, Lesley A.

AU - Villarin, Al

AU - Ruffenach, Stephen J.

AU - Prosnitz, Eric H.

AU - Salmon, Julia V.

PY - 1996/12

Y1 - 1996/12

N2 - A 31-y-old epileptic man developed coma and shock after suicidally ingesting large amounts of valproic acid and gabapentin. His peak valproic acid level was 1306.9 μg/mL (therapeutic range = 30-100 μg/mL). His peak gabapentin level was 60.0 μg/mL (therapeutic range = 2.0-8.0 μg/mL). His hypotension was refractory to crystalloid and pressor infusions, but resolved during concurrent hemoperfusion and hemodialysis to enhance elimination of valproic acid. Concurrent hemoperfusion and hemodialysis, in series, produced a maximum valproic acid plasma clearance of 55.4 mL/min versus a maximum reported intrinsic valproic acid plasma clearance of 10.6 mL/min. Concurrent hemoperfusion and hemodialysis, in series, should be considered in hemodynamically unstable patients with valproic acid poisoning whose clinical condition is worsening in spite of aggressive supportive care.

AB - A 31-y-old epileptic man developed coma and shock after suicidally ingesting large amounts of valproic acid and gabapentin. His peak valproic acid level was 1306.9 μg/mL (therapeutic range = 30-100 μg/mL). His peak gabapentin level was 60.0 μg/mL (therapeutic range = 2.0-8.0 μg/mL). His hypotension was refractory to crystalloid and pressor infusions, but resolved during concurrent hemoperfusion and hemodialysis to enhance elimination of valproic acid. Concurrent hemoperfusion and hemodialysis, in series, produced a maximum valproic acid plasma clearance of 55.4 mL/min versus a maximum reported intrinsic valproic acid plasma clearance of 10.6 mL/min. Concurrent hemoperfusion and hemodialysis, in series, should be considered in hemodynamically unstable patients with valproic acid poisoning whose clinical condition is worsening in spite of aggressive supportive care.

UR - http://www.scopus.com/inward/record.url?scp=0029856933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029856933&partnerID=8YFLogxK

M3 - Article

C2 - 8948077

AN - SCOPUS:0029856933

VL - 38

SP - 438

EP - 443

JO - Veterinary and Human Toxicology

JF - Veterinary and Human Toxicology

SN - 0145-6296

IS - 6

ER -